R Nadeau

Phase I trial of subcutaneous recombinant human interleukin-12 in patients with advanced renal cell carcinoma.

Robert J. Motzer, Ashok Rakhit, Lawrence H. Schwartz et al. · PubMed · 1998 · 231 citations

Immunology, Immunoediting, Pharmacotherapy +16

Pilot study of subcutaneous recombinant human interleukin 12 in metastatic melanoma.

Emilio Bajetta, Michele Del Vecchio, Roberta Mortarini et al. · PubMed · 1998 · 165 citations

Immunology, Pharmacotherapy, Il-12 Levels +18

Use of an indirect pharmacodynamic stimulation model of MX protein induction to compare in vivo activity of interferon alfa-2a and a polyethylene glycol-modified derivative in healthy subjects

Keith Nieforth, R Nadeau, Indravadan H. Patel et al. · Clinical Pharmacology & Therapeutics · 1996 · 84 citations

Long term efficacy and toxicity of amiodarone in the treatment of refractory cardiac arrhythmias.

R Primeau, Ali Agha, C. Giorgi et al. · PubMed · 1989 · 25 citations

Pharmacokinetics of teceleukin (recombinant human interleukin-2) after intravenous or subcutaneous administration to patients with cancer.

Linda E. Gustavson, R Nadeau, Neil F. Oldfield · PubMed · 1989 · 23 citations

Subcutaneous Injections, Immunology, Pathology +16